AP
Andrea-Clemencia Pineda-Peña
Research areas: Medicine · Infectious Diseases · HIV/AIDS Research and Interventions · HIV Research and Treatment · HIV/AIDS drug development and treatment
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (43)
- Randomized Controlled Trial of the Immunogenicity and Safety of a Serum-Free Purified Vero Rabies Vaccine (PVRV-NG2) Using a Simulated Postexposure Zagreb Regimen With Human Rabies Immunoglobulin in Adults in Thailand Save
- The impact of immigration on tuberculosis and HIV burden between Colombia and Venezuela and across frontier regions Save
- Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations Save
- Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017 Save
- Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa Save
- Drivers of HIV-1 transmission: The Portuguese case Save
- Tracing the Impact of Public Health Interventions on HIV-1 Transmission in Portugal Using Molecular Epidemiology Save
- Association of HIV status with infection by multiple HPV types Save
- HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012 Save
- The impact of HIV-1 within-host evolution on transmission dynamics Save
- The impact of HIV-1 within-host evolution on transmission dynamics Save
- Zika genomics urgently need standardized and curated reference sequences Save
- Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy Save
- A21HIV-1 sub-subtype F1 outbreak among MSM in Belgium. Save
- Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users Save
- On the contribution of Angola to the initial spread of HIV-1 Save
- BEST HOPE - Cohort of HIV newly diagnosed patients in Portugal Save
- Founder effect of NS3 variant Q80K in the global HCV1a variability Save
- HIV-1 sub-subtype F1 outbreak among MSM in Belgium Save
- Founder effect of NS3 variant Q80K in HCV1a infected patients in Italy Save